Andrea Gräfe

740 total citations
11 papers, 60 citations indexed

About

Andrea Gräfe is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Andrea Gräfe has authored 11 papers receiving a total of 60 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Andrea Gräfe's work include Advanced Breast Cancer Therapies (5 papers), HER2/EGFR in Cancer Research (5 papers) and Breast Cancer Treatment Studies (4 papers). Andrea Gräfe is often cited by papers focused on Advanced Breast Cancer Therapies (5 papers), HER2/EGFR in Cancer Research (5 papers) and Breast Cancer Treatment Studies (4 papers). Andrea Gräfe collaborates with scholars based in Germany and Switzerland. Andrea Gräfe's co-authors include Thomas Fuchs, Rainer Rupprecht, Claudia Vente, T Hitschold, Claus Lattrich, W. Fett, Tobias Hesse, Lars Hanker, Volkmar Müller and Andreas Schneeweiß and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Allergy.

In The Last Decade

Andrea Gräfe

9 papers receiving 60 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrea Gräfe Germany	5	20	18	14	10	8	11	60
Kyomin Choi South Korea	7	9 0.5×	10 0.6×	18 1.3×	7 0.7×		22	109
Zahari Zahariev Bulgaria	6	16 0.8×	6 0.3×	13 0.9×	22 2.2×	2 0.3×	23	106
Francesco Masini Italy	6	6 0.3×	11 0.6×	6 0.4×	5 0.5×	3 0.4×	18	88
Antía Moreira Spain	6	16 0.8×	9 0.5×	14 1.0×	4 0.4×	4 0.5×	14	99
Karen Naismith United Kingdom	4	9 0.5×	5 0.3×	4 0.3×	11 1.1×	9 1.1×	4	68
Sigita Stropuvienë Lithuania	5	7 0.3×	48 2.7×	3 0.2×	5 0.5×	3 0.4×	10	85
Qin Song China	6	4 0.2×	25 1.4×	22 1.6×	7 0.7×	3 0.4×	15	107
Nathan Thibault United States	6	18 0.9×	36 2.0×	3 0.2×	7 0.7×	11 1.4×	17	100
Erin Huggins United States	6	9 0.5×	40 2.2×	5 0.4×	4 0.4×	7 0.9×	13	110
Manisha Kak United States	4	7 0.3×	10 0.6×	16 1.1×	32 3.2×	45 5.6×	5	78

Countries citing papers authored by Andrea Gräfe

Since Specialization

Citations

This map shows the geographic impact of Andrea Gräfe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Gräfe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Gräfe more than expected).

Fields of papers citing papers by Andrea Gräfe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Gräfe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Gräfe. The network helps show where Andrea Gräfe may publish in the future.

Co-authorship network of co-authors of Andrea Gräfe

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Gräfe. A scholar is included among the top collaborators of Andrea Gräfe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Gräfe. Andrea Gräfe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Thill, Marc, Pauline Wimberger, Andrea Gräfe, et al.. (2022). Dual HER2 blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T: results from a German non-interventional study (NIS) HELENA (NCT01777958). Breast Cancer Research and Treatment. 196(2). 311–321. 2 indexed citations

Thill, Marc, Andrea Gräfe, Peter Klare, et al.. (2022). Abstract P2-13-16: Dual HER2-blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T. Results from a German non-interventional study (NIS) HELENA (NCT01777958). Cancer Research. 82(4_Supplement). P2–13. 1 indexed citations

Müller, Volkmar, Markus Ruhnke, Oliver Hoffmann, et al.. (2021). First-line bevacizumab-containing therapy for HER2-negative locally advanced/metastatic breast cancer: Real-world experience from >2000 patients treated in the multicentre AVANTI study. The Breast. 60. 70–77. 4 indexed citations

Hanker, Lars, Frank Förster, Andrea Gräfe, et al.. (2020). Resumption of Trastuzumab in Patients With Disease Recurrence After (Neo-) Adjuvant Anti-HER2-therapy in Patients With HER2-positive Breast Cancer. Anticancer Research. 40(7). 3973–3981. 5 indexed citations

Wuerstlein, Rachel, Nadia Harbeck, Eva‐Maria Grischke, et al.. (2020). Protroca: A Noninterventional Study on Prophylactic Lipegfilgrastim against Chemotherapy-Induced Neutropenia in Nonselected Breast Cancer Patients. Breast Care. 16(1). 50–58.

Müller, Volkmar, Andreas Jakob, Bahriye Aktas, et al.. (2016). Abstract P4-13-26: Efficacy, safety, and treatment decision-making in the AVANTI German observational study of first-line bevacizumab (BEV)-containing therapy for locally advanced, recurrent, or metastatic breast cancer (aBC). Cancer Research. 76(4_Supplement). P4–13. 1 indexed citations

Schneeweiß, Andreas, et al.. (2013). Abstract P4-14-04: AVANTI: A non-interventional study examining the combination of bevacizumab with paclitaxel or capecitabine in metastatic breast cancer. Cancer Research. 73(24_Supplement). P4–14. 2 indexed citations

Hanker, Lars, T Hitschold, Tobias Hesse, et al.. (2013). Efficacy of trastuzumab re-therapy in routine treatment of HER2-positive breast cancer patients who relapsed after completed (neo-)adjuvant anti-HER2 therapy.. Journal of Clinical Oncology. 31(15_suppl). 602–602.

Rupprecht, Rainer, Claudia Vente, Andrea Gräfe, & Thomas Fuchs. (1999). Angioedema due to losartan. Allergy. 54(1). 81–82. 13 indexed citations

10.

Gräfe, Andrea. (1999). Fibromyalgia in Lupus Erythematosus. Acta Dermato Venereologica. 79(1). 62–64. 28 indexed citations

11.

Gräfe, Andrea, et al.. (1971). Virustatische Behandlung eruptiver Warzen. DMW - Deutsche Medizinische Wochenschrift. 96(48). 1863–1866. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact